Xuzhou Third People's Hospital
7
0
0
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
The Safety and Efficacy of New-Generation BRS vs. DCB for De Novo Large Coronary Artery Lesions: A Prospective RCT
Role: lead
Biolimus-Coated Balloon in de Novo Large Vessel Coronary Lesions
Role: lead
Intravascular Lithotripsy for Acute Stent Under-expansion in Calcified Coronary Lesions
Role: lead
Yao Strategy for the Treatment of de Novo Medina 0,1,0 or 0,0,1 Bifurcation Lesion
Role: lead
Clinical Efficacy and Safety of a Prospective, Multicenter Drug Coated Balloon for Left Main Artery Disease in China
Role: lead
OCT Evaluation of Early Vascular Repair in Patients With Non ST Elevation Acute Coronary Syndrome (NSTE-ACS)
Role: lead
Paclitaxel Eluting Balloon Catheter in Coronary De-novo Lesions Treatment in China
Role: collaborator
All 7 trials loaded